• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why IMARA Jumped Around 75%; Here Are 54 Biggest Movers From Yesterday

    9/8/22 5:26:06 AM ET
    $ADTH
    $AKA
    $AMRS
    $AQST
    Computer Software: Programming Data Processing
    Technology
    Catalog/Specialty Distribution
    Consumer Discretionary
    Get the next $ADTH alert in real time by email

    Gainers

    • IMARA Inc. (NASDAQ:IMRA) jumped 74.8% to settle at $2.01 on Wednesday after the company announced it entered into an asset purchase agreement with Cardurion Pharmaceuticals to sell tovinontrine and other assets of its PDE9 program for $34.75 million upfront.
    • Azure Power Global Limited (NYSE:AZRE) shares jumped 35.4% to close at $4.86. Azure Power Global recently announced the resignation of Harsh Shah as CEO.
    • SelectQuote, Inc. (NYSE:SLQT) rose 28.8% to close at $1.43.
    • Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ:SHPH) gained 27.7% to close at $36.40 amid post-IPO volatility.
    • Spero Therapeutics, Inc. (NASDAQ:SPRO) shares jumped 26.6% to close at $1.43. Spero Therapeutics shares jumped over 55% on Tuesday after the company received minutes from a Type A meeting with the FDA discussing steps required to resubmit the marketing application for tebipenem HBr.
    • a.k.a. Brands Holding Corp. (NYSE:AKA) gained 23.7% to settle at $2.92 amid overall market strength as stocks rebound from recent weakness.
    • Pingtan Marine Enterprise Ltd. (NASDAQ:PME) climbed 23.3% to close at $0.8998.
    • Nutex Health, Inc. (NASDAQ:NUTX) gained 21.9% to close at $3.17.
    • Molecular Templates, Inc. (NASDAQ:MTEM) rose 21.8% to close at $0.83. Molecular Templates said on August 31, it received notice from Nasdaq that the company no longer meets minimum bid price requirement.
    • Reata Pharmaceuticals, Inc. (NASDAQ:RETA) jumped 21.1% to settle at $27.07.
    • Amyris, Inc. (NASDAQ:AMRS) gained 19.6% to settle at $3.24.
    • Latch, Inc. (NASDAQ:LTCH) jumped 19.2% to close at $1.24.
    • Tupperware Brands Corporation (NYSE:TUP) gained 19.2% to settle at $8.77 amid overall market strength as stocks rebound from recent weakness.
    • Vicarious Surgical Inc. (NASDAQ:RBOT) rose 18.8% to close at $4.37. Vicarious Surgical, last month, posted a Q2 loss of $0.16 per share.
    • Biophytis S.A. (NASDAQ:BPTS) shares gained 18.1% to close at $1.11 after the company released topline results from its phase 2-3 COVA study evaluating Sarconeos (BIO101) in treating COVID-19-related respiratory failure.
    • Glaukos Corporation (NYSE:GKOS) climbed 18.5% to close at $57.01 after the company announced topline data for both Phase 3 pivotal trials of iDose TR that successfully achieved its pre-specified primary efficacy endpoints through 3 months in both Phase 3 trials and demonstrated excellent tolerability and a favorable safety profile through 12 months.
    • Coupa Software Incorporated (NASDAQ:COUP) jumped 17.9% to close at $65.82 as the company posted better-than-expected results for its second quarter and issued strong forecast for FY23. The company also announced a $100 million buyback program.
    • Quoin Pharmaceuticals, Ltd. (NASDAQ:QNRX) shares gained 17.8% to close at $3.91 after Alliance Global Partners initiated coverage on the stock with a Buy rating and a $20 price target.
    • Aquestive Therapeutics, Inc. (NASDAQ:AQST) rose 17.6% to close at $1.47. Oppenheimer initiated coverage on Aquestive Therapeutics with an Outperform rating and announced a price target of $8.5.
    • Seres Therapeutics, Inc. (NASDAQ:MCRB) rose 17% to close at $6.32. Seres Therapeutics announced completion of rolling BLA submission to the FDA for investigational microbiome therapeutic SER-109 for recurrent C. Difficile infection.
    • SAI.TECH Global Corporation (NASDAQ:SAI) jumped 15.3% to close at $5.42.
    • Sidus Space, Inc. (NASDAQ:SIDU) gained 14.7% to close at $3.05 after the company announced that it has signed a launch agreement with SpaceX for five launches, beginning in early 2023.
    • GitLab Inc. (NASDAQ:GTLB) surged 14.3% to settle at $54.16 following Q2 results.
    • SunPower Corporation (NASDAQ:SPWR) gained 14.4% to close at $27.37.
    • Academy Sports and Outdoors, Inc. (NASDAQ:ASO) jumped 14% to close at $47.81. Academy Sports And Outdoors reported a second-quarter FY22 sales decline of 5.8% year-on-year to $1.69 billion.
    • Penumbra, Inc. (NYSE:PEN) gained 13.2% to close at $185.90. Penumbra, last month, reported better-than-expected Q2 EPS and sales results.
    • Baudax Bio, Inc. (NASDAQ:BXRX) rose 12.9% to close at $0.3399 after declining over 7% on Tuesday. Baudax Bio recently announced the pricing of a $6.2 million public offering.
    • SolarEdge Technologies, Inc. (NASDAQ:SEDG) jumped 11.9% to close at $311.36. Shares of several solar companies at large traded higher in possible reaction to the recent signing of the Inflation Reduction Act. The European gas crisis could also be positively impacting solar stocks, as countries look for alternatives to gas.
    • Tempur Sealy International, Inc. (NYSE:TPX) gained 11.6% to settle at $27.24.
    • Unico American Corporation (NASDAQ:UNAM) gained 9.5% to close at $1.84.
    • bioAffinity Technologies, Inc. (NASDAQ:BIAF) gained 6.7% to close at $5.75 after dropping around 24% on Tuesday. The company, last week, priced its IPO at $6.125 per unit.

     

     

    Losers

    • Great Panther Mining Limited (NYSE:GPL) dipped 60.1% to close at $0.3232 on Wednesday. Great Panther recently announced it will file a notice of intention to make a proposal under the Bankruptcy and Insolvency Act (Canada).
    • CleanTech Acquisition Corp. (NASDAQ:CLAQ) shares fell 28.5% to close at $6.77 after the company reported shareholder voting results in 8K filing.
    • NewAge, Inc. (NASDAQ:NBEV) shares fell 25.2% to close at $0.0935 after dipping over 15% on Tuesday. The company recently announced it filed a voluntary petition for relief under chapter 11 of the United States Bankruptcy Code.
    • First Wave BioPharma, Inc. (NASDAQ:FWBI) shares fell 23.2% to close at $3.24 after jumping around 33% on Tuesday. First Wave BioPharma recently announced a 1:30 reverse stock split.
    • Veru Inc. (NASDAQ:VERU) declined 21.1% to close at $11.51. Traders circulate word FDA decision on the company’s COVID treatment coming on Oct. 6.
    • BioSig Technologies, Inc. (NASDAQ:BSGM) dropped 18.8% to settle at $0.8201.
    • Presidio Property Trust, Inc. (NASDAQ:SQFT) fell 16.8% to close at $1.73. Presidio Property Trust recently declared Q3 dividend and adopted variable dividend policy.
    • Avalo Therapeutics, Inc. (NASDAQ:AVTX) dropped 15% to settle at $4.99.
    • AdTheorent Holding Company, Inc. (NASDAQ:ADTH) fell 15% to close at $2.32.
    • American Virtual Cloud Technologies, Inc. (NASDAQ:AVCT) declined 14.8% to close at $0.1875. American Virtual Cloud Technologies recently announced an equity distribution agreement to offer and sell up to $14.7 million shares of common stock.
    • Golden Path Acquisition Corporation (NASDAQ:GPCO) dropped 13.4% to close at $8.88.
    • Kaspien Holdings Inc. (NASDAQ:KSPN) fell 12.2% to close at $2.23.
    • FaZe Holdings Inc. (NASDAQ:FAZE) fell 11.9% to close at $12.10.
    • Korn Ferry (NYSE:KFY) fell 11.6% to close at $53.24 following downbeat quarterly earnings.
    • UiPath Inc. (NYSE:PATH) fell 11.2% to close at $13.84 after the company issued Q3 and FY23 sales guidance below analyst estimates.
    • Mobile Global Esports Inc. (NASDAQ:MGAM) dropped 10.3% to close at $2.45.
    • John Wiley & Sons, Inc. (NYSE:WLY) fell 9.8% to close at $41.58 after the company reported worse-than-expected Q1 EPS and sales results.
    • Vacasa, Inc. (NASDAQ:VCSA) fell 8.4% to close at $3.69.
    • Cogent Communications Holdings, Inc. (NASDAQ:CCOI) declined 8.3% to close at $49.63. Cogent Communications agreed to snap T-Mobile US, Inc's (NASDAQ:TMUS) Wireline Business.
    • AMTD Digital Inc. (NYSE:HKD) dropped 8.2% to settle at $63.27.
    • Vermilion Energy Inc. (NYSE:VET) fell 7.6% to close at $23.26 amid a drop in oil prices as economic concerns weigh on demand outlook.
    • G-III Apparel Group, Ltd. (NASDAQ:GIII) dropped 5.6% to close at $18.73 after the company posted downbeat quarterly earnings and lowered FY23 forecast.
    • GameStop Corp. (NYSE:GME) fell 4.4% to close at $24.04. The company released quarterly earnings after the closing bell on Wednesday.
    Get the next $ADTH alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ADTH
    $AKA
    $AMRS
    $AQST

    CompanyDatePrice TargetRatingAnalyst
    GitLab Inc.
    $GTLB
    4/22/2026$27.00Buy → Neutral
    BofA Securities
    GitLab Inc.
    $GTLB
    4/20/2026$25.00Outperform → Sector Perform
    RBC Capital Mkts
    T-Mobile US Inc.
    $TMUS
    4/16/2026$260.00Overweight
    Morgan Stanley
    GitLab Inc.
    $GTLB
    4/16/2026$24.00Buy → Neutral
    UBS
    SolarEdge Technologies Inc.
    $SEDG
    4/15/2026$31.00Neutral → Sell
    Goldman
    T-Mobile US Inc.
    $TMUS
    4/13/2026$260.00Sector Weight → Overweight
    KeyBanc Capital Markets
    Avalo Therapeutics Inc.
    $AVTX
    4/9/2026$48.00Outperform
    Wolfe Research
    GitLab Inc.
    $GTLB
    4/9/2026Buy → Neutral
    Guggenheim
    More analyst ratings

    $ADTH
    $AKA
    $AMRS
    $AQST
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Bitwise Announces Monthly Distributions for IMST, ICOI, IMRA, IGME, ICRC, and IETH

    SAN FRANCISCO, April 23, 2026 /PRNewswire/ -- Bitwise Asset Management, a leading crypto asset manager, today announced the monthly distributions for its suite of Option Income Strategy ETFs: IMST, ICOI, IMRA, IGME, ICRC, and IETH. FundTickerDistribution Per ShareDistribution Rate30-Day SEC YieldReturn of CapitalEx-Date / Record DatePayment Date1-Month Return1-Year ReturnSince InceptionReturn*Bitwise COINOption Income Strategy ETFICOI$0.2544725.40 %0.00 %100.00 %4/24/20264/28/2026-4.73 %-28.24 %-24.19 %Bitwise MARAOption Income Strategy ETFIMRA$0.1476311.25 %0.00 %100.00 %4/24/2

    4/23/26 5:06:00 PM ET
    $IMRA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Sidus Space Advances its Fortis Next-Generation Command and Data Handling (C&DH) System

    Microchip collaboration enables accelerated, modular, and mission‑scalable OpenVPX architectures for space and defense applications CAPE CANAVERAL, Fla., April 23, 2026 /PRNewswire/ -- Sidus Space, Inc. (NASDAQ:SIDU) ("Sidus" or the "Company"), an innovative space and defense technology company, today announced continued advancements to its Fortis Command and Data Handling (C&DH) platform, a modular 3U OpenVPX system designed to support rapid development, configuration flexibility, and long-term scalability across next-generation space and defense missions. Supported by a strate

    4/23/26 8:31:00 AM ET
    $SIDU
    Telecommunications Equipment
    Telecommunications

    Nutex Health Schedules 2026 First Quarter Financial Results Release and Conference Call

    HOUSTON, April 22, 2026 /PRNewswire/ -- Nutex Health, Inc. (NASDAQ:NUTX), a physician-led, integrated healthcare delivery system comprised of 27 state-of-the-art micro hospitals and hospital outpatient departments in 12 states and primary care-centric, risk-bearing physician networks, today announced that it plans to file its Form 10-Q for the first fiscal quarter ended March 31, 2026, on Thursday, April 30, 2026 after the market close. The Company will also issue a corresponding press release summarizing financial results on the same day. Nutex Health will host its earnings conference call on Friday, May 1, 2026, at 9:30 a.m. CT to discuss the Company's financial performance and provide a b

    4/22/26 4:15:00 PM ET
    $NUTX
    Real Estate

    $ADTH
    $AKA
    $AMRS
    $AQST
    SEC Filings

    View All

    SEC Form 425 filed by Penumbra Inc.

    425 - Penumbra Inc (0001321732) (Subject)

    4/23/26 4:18:26 PM ET
    $PEN
    Medical/Dental Instruments
    Health Care

    SEC Form 8-K filed by T-Mobile US Inc.

    8-K - T-Mobile US, Inc. (0001283699) (Filer)

    4/23/26 4:16:34 PM ET
    $TMUS
    Telecommunications Equipment
    Telecommunications

    Nutex Health Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

    8-K - Nutex Health Inc. (0001479681) (Filer)

    4/23/26 4:05:58 PM ET
    $NUTX
    Real Estate

    $ADTH
    $AKA
    $AMRS
    $AQST
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for LIBERVANT issued to AQUESTIVE THERAPEUTICS INC

    Submission status for AQUESTIVE THERAPEUTICS INC's drug LIBERVANT (ORIG-1) with active ingredient DIAZEPAM has changed to 'Approval' on 04/26/2024. Application Category: NDA, Application Number: 218623, Application Classification: Type 9 - New Indication Submitted as Distinct NDA, Consolidated with Original NDA after Approval

    4/29/24 7:48:13 AM ET
    $AQST
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for IDOSE TR issued to GLAUKOS CORP

    Submission status for GLAUKOS CORP's drug IDOSE TR (ORIG-1) with active ingredient TRAVOPROST has changed to 'Approval' on 12/13/2023. Application Category: NDA, Application Number: 218010, Application Classification: Type 3 - New Dosage Form

    12/15/23 11:41:09 AM ET
    $GKOS
    Medical/Dental Instruments
    Health Care

    FDA Approval for TRAVOPROST issued to GLAUKOS CORP

    Submission status for GLAUKOS CORP's drug TRAVOPROST (ORIG-1) with active ingredient TRAVOPROST has changed to 'Approval' on 12/13/2023. Application Category: NDA, Application Number: 218010, Application Classification: Type 3 - New Dosage Form

    12/14/23 7:41:03 AM ET
    $GKOS
    Medical/Dental Instruments
    Health Care

    $ADTH
    $AKA
    $AMRS
    $AQST
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Legal Officer-Healthcare Montgomery Pamela W. bought $7,021 worth of shares (79 units at $88.87), increasing direct ownership by 3% to 2,758 units (SEC Form 4)

    4 - Nutex Health Inc. (0001479681) (Issuer)

    3/16/26 3:02:43 PM ET
    $NUTX
    Real Estate

    PRESIDENT Grant Robert Clay bought $105,024 worth of shares (118,901 units at $0.88) (SEC Form 4)

    4 - SelectQuote, Inc. (0001794783) (Issuer)

    2/19/26 4:11:41 PM ET
    $SLQT
    Specialty Insurers
    Finance

    Director Cheng Lawrence bought $114,368 worth of shares (5,000 units at $22.87) (SEC Form 4)

    4 - GameStop Corp. (0001326380) (Issuer)

    1/26/26 9:06:47 AM ET
    $GME
    Electronics Distribution
    Consumer Discretionary

    $ADTH
    $AKA
    $AMRS
    $AQST
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    GitLab downgraded by BofA Securities with a new price target

    BofA Securities downgraded GitLab from Buy to Neutral and set a new price target of $27.00

    4/22/26 7:53:14 AM ET
    $GTLB
    Computer Software: Prepackaged Software
    Technology

    GitLab downgraded by RBC Capital Mkts with a new price target

    RBC Capital Mkts downgraded GitLab from Outperform to Sector Perform and set a new price target of $25.00

    4/20/26 8:23:59 AM ET
    $GTLB
    Computer Software: Prepackaged Software
    Technology

    Morgan Stanley resumed coverage on T-Mobile US with a new price target

    Morgan Stanley resumed coverage of T-Mobile US with a rating of Overweight and set a new price target of $260.00

    4/16/26 8:05:25 AM ET
    $TMUS
    Telecommunications Equipment
    Telecommunications

    $ADTH
    $AKA
    $AMRS
    $AQST
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 3 filed by new insider Salmons Ryan D

    3 - Latch, Inc. (0001826000) (Issuer)

    4/17/26 5:29:18 PM ET
    $LTCH
    EDP Services
    Technology

    SEC Form 3 filed by new insider Malone James M

    3 - Latch, Inc. (0001826000) (Issuer)

    4/17/26 10:26:22 AM ET
    $LTCH
    EDP Services
    Technology

    SEC Form 4 filed by Tweedy Jeffrey C.

    4 - Academy Sports & Outdoors, Inc. (0001817358) (Issuer)

    4/17/26 8:59:24 AM ET
    $ASO
    Other Specialty Stores
    Consumer Discretionary

    $ADTH
    $AKA
    $AMRS
    $AQST
    Leadership Updates

    Live Leadership Updates

    View All

    Aquestive Therapeutics Announces New Role of Lori J. Braender and Appointment of Thomas A. Zalewski as Chief Legal Officer and Chief Compliance Officer

    Thomas A. Zalewski, a Partner at Day Pitney LLP, appointed Chief Legal Officer and Chief Compliance Officer effective April 2, 2026Lori J. Braender to remain in a non-executive role as Corporate Secretary after nearly eight years as Chief Legal Officer, Chief Compliance Officer and Corporate Secretary WARREN, N.J., March 20, 2026 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ:AQST) ("Aquestive" or the "Company"), a pharmaceutical company advancing medicines to bring meaningful improvement to patients' lives through innovative science and delivery technologies, today announced the appointment of Thomas A. Zalewski as Chief Legal Officer and Chief Compliance Officer, effective Apr

    3/20/26 7:00:00 AM ET
    $AQST
    Biotechnology: Pharmaceutical Preparations
    Health Care

    The $17 Billion Solar Maintenance Market Just Got a New Player From the Defense Sector

    Issued on behalf of VisionWave Holdings, Inc. Companies mentioned in this article: VisionWave Holdings (NASDAQ:VWAV), First Solar (NASDAQ:FSLR), Enphase Energy (NASDAQ:ENPH), SunPower (NASDAQ:SPWR), SolarEdge Technologies (NASDAQ:SEDG) Key Takeaways: VisionWave Holdings (NASDAQ:VWAV) subsidiary SolarDrone has acquired a 51% controlling interest in Junko Solar, an Israeli solar panel maintenance and cleaning company, and appointed its founder Amos Cohen as SolarDrone CEO.The global solar panel operation and maintenance market is valued at $17 billion in 2026 and projected to reach nearly $60 billion by 2035, growing at a 13.3% CAGR[1].First Solar inaugurated a $1.1 billion AI-enabled manuf

    3/17/26 9:00:00 AM ET
    $ENPH
    $FSLR
    $SEDG
    Semiconductors
    Technology
    Computer Software: Prepackaged Software

    Seres Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates

    Readout of investigator-sponsored SER-155 study in immune checkpoint–related enterocolitis, a frequent and serious side effect in cancer patients treated with immune checkpoint inhibitors, on track for Q2 2026  Seres operational focus on advancing live biotherapeutic programs for inflammatory and immune diseases Company working to create meaningful partnerships with collaborators to support continued development of pipeline programs, including SER-155 for allogeneic hematopoietic stem cell transplant (allo-HSCT)  CAMBRIDGE, Mass., March 12, 2026 (GLOBE NEWSWIRE) -- Seres Therapeutics, Inc. (NASDAQ:MCRB), (Seres or the Company), a leading live biotherapeutics company, today reported fou

    3/12/26 7:00:00 AM ET
    $MCRB
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ADTH
    $AKA
    $AMRS
    $AQST
    Financials

    Live finance-specific insights

    View All

    Bitwise Announces Monthly Distributions for IMST, ICOI, IMRA, IGME, ICRC, and IETH

    SAN FRANCISCO, April 23, 2026 /PRNewswire/ -- Bitwise Asset Management, a leading crypto asset manager, today announced the monthly distributions for its suite of Option Income Strategy ETFs: IMST, ICOI, IMRA, IGME, ICRC, and IETH. FundTickerDistribution Per ShareDistribution Rate30-Day SEC YieldReturn of CapitalEx-Date / Record DatePayment Date1-Month Return1-Year ReturnSince InceptionReturn*Bitwise COINOption Income Strategy ETFICOI$0.2544725.40 %0.00 %100.00 %4/24/20264/28/2026-4.73 %-28.24 %-24.19 %Bitwise MARAOption Income Strategy ETFIMRA$0.1476311.25 %0.00 %100.00 %4/24/2

    4/23/26 5:06:00 PM ET
    $IMRA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Nutex Health Schedules 2026 First Quarter Financial Results Release and Conference Call

    HOUSTON, April 22, 2026 /PRNewswire/ -- Nutex Health, Inc. (NASDAQ:NUTX), a physician-led, integrated healthcare delivery system comprised of 27 state-of-the-art micro hospitals and hospital outpatient departments in 12 states and primary care-centric, risk-bearing physician networks, today announced that it plans to file its Form 10-Q for the first fiscal quarter ended March 31, 2026, on Thursday, April 30, 2026 after the market close. The Company will also issue a corresponding press release summarizing financial results on the same day. Nutex Health will host its earnings conference call on Friday, May 1, 2026, at 9:30 a.m. CT to discuss the Company's financial performance and provide a b

    4/22/26 4:15:00 PM ET
    $NUTX
    Real Estate

    NYSE Content Update: UiPath Celebrates Five-Year Listing Anniversary at NYSE

    NYSE issues a pre-market daily advisory direct from the trading floor.NEW YORK, April 21, 2026 /CNW/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins.  Ashley Mastronardi delivers the pre-market update on April 21stThe major averages are climbing Tuesday morning as investors react to the latest developments in Iran and fresh earnings.UiPath (NYSE:PATH) CMO Michael Atalla will join NYSE Live to discuss his company's five-year anniversary as a listed company.HSBC (NYSE:HSBC) Innovation Banking Managing Director Jonathan Norris

    4/21/26 8:55:00 AM ET
    $HSBC
    $ICE
    $PATH
    Savings Institutions
    Finance
    Investment Bankers/Brokers/Service
    Computer Software: Prepackaged Software

    $ADTH
    $AKA
    $AMRS
    $AQST
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Latch Inc.

    SC 13G - Latch, Inc. (0001826000) (Subject)

    12/13/24 9:45:09 PM ET
    $LTCH
    EDP Services
    Technology

    Amendment: SEC Form SC 13D/A filed by Latch Inc.

    SC 13D/A - Latch, Inc. (0001826000) (Subject)

    12/2/24 4:44:02 PM ET
    $LTCH
    EDP Services
    Technology

    Amendment: SEC Form SC 13G/A filed by Molecular Templates Inc.

    SC 13G/A - Molecular Templates, Inc. (0001183765) (Subject)

    11/18/24 9:49:56 PM ET
    $MTEM
    Biotechnology: Pharmaceutical Preparations
    Health Care